Phase 1 trial of durvalumab (anti-PD-L1) combined with lenalidomide in relapsed/refractory cutaneous T-cell lymphoma. [PDF]
Querfeld C+14 more
europepmc +1 more source
No Longer Cutaneous T-cell Lymphoma Dermal Nodule. [PDF]
Yousif ML, Zhao X, Andrews D.
europepmc +1 more source
ABSTRACT A 5‐year‐old male with xeroderma pigmentosum from Honduras presented with a rapidly growing mass on the left post‐auricular neck, associated with left‐sided hearing loss. MRI revealed a large mass with invasion of the external auditory canal, temporal bone, and metastasis to lymph nodes. Biopsy confirmed moderately differentiated squamous cell
Ngan Do+4 more
wiley +1 more source
Structural Insights into the ADCC Mechanism and Resistance of Mogamulizumab, a First-in-Class Anti-CCR4 Therapy for Cutaneous T Cell Lymphoma. [PDF]
Choi SB+7 more
europepmc +1 more source
Prognosis and Staging of Cutaneous T-cell Lymphoma
Francine M. Foss, Edward A. Sausville
openalex +1 more source
Fine-Needle Aspiration Biopsy in the Evaluation of Lymphadenopathy Associated With Cutaneous T-Cell Lymphoma (Mycosis Fungoides/Sézary Syndrome) [PDF]
Lorenzo M. Galindo+6 more
openalex +1 more source
Memory T-Cell Phenotype in Cutaneous T-Cell Lymphoma Is Modified by Germline Gene Gametocyte Specific Factor 1. [PDF]
Martínez Villarreal A+5 more
europepmc +1 more source
Lymphoma‐ and leukemia‐associated cutaneous atypical CD30+ T‐cell reactions [PDF]
Lyndon D. Su, Lyn M. Duncan
openalex +1 more source
Polo‐like kinases and UV‐induced skin carcinogenesis: What we know and what's next
The polo‐like kinase (PLK) family plays distinct and critical roles in the regulation of cell cycle progression, and its dysregulation has been implicated in various cancers. Ultraviolet (UV) radiation is a well‐established environmental factor in the development of skin cancer.
Tanya Jaiswal+3 more
wiley +1 more source